52173-03-2

Upstream product

• 68-12-2 N,N-dimethyl-formamide 
• 86-92-0 3-methyl-1-(4-methylphenyl)-2-pyrazolin-5-one 

Downstream Products

• 1211565-26-2 N,N-bis-(3,5-dimethyl-1-p-tolyl-1H-pyrazol-4-ylmethylene)-ethane-1,2-diamine 
• 1211565-28-4 N,N-bis-(3,5-dimethyl-1-p-tolyl-1H-pyrazol-4-ylmethylene)-benzene-1,2-diamine 
• 1207671-52-0 C₄₃H₅₄N₂O₅ 
• 1207671-51-9 C₄₁H₅₀N₂O₅ 
• 1207671-50-8 C₃₉H₄₆N₂O₅ 
• 1207671-45-1 C₃₂H₃₂N₂O₅ 
• 1207671-44-0 C₃₁H₃₀N₂O₅ 
• 1207671-43-9 C₃₀H₂₈N₂O₅ 
• 1207671-42-8 C₂₉H₂₆N₂O₅ 
• 1207671-41-7 C₂₈H₂₄N₂O₅ 
• 1207671-49-5 C₃₇H₄₂N₂O₅ 
• 1207671-48-4 C₃₅H₃₈N₂O₅ 
• 1207671-47-3 C₃₄H₃₆N₂O₅ 
• 1207671-46-2 C₃₃H₃₄N₂O₅ 

Relevant academic research and scientific papers

Pyrazolone as a recognition site: Rhodamine 6G-based fluorescent probe for the selective recognition of Fe3+ in acetonitrile-aqueous solution

Two novel Rhodamine-pyrazolone-based colorimetric off-on fluorescent chemosensors for Fe3+ ions were designed and synthesized using pyrazolone as the recognition moiety and Rhodamine 6G as the signalling moiety. The photophysical properties and

Quinazolin-4-one derivatives

A medicament having an inhibitory activity against hematopoietic prostaglandin D2 synthase, which comprises as an active ingredient a compound represented by the following general formula (I) or a salt thereof: wherein X represents a group represented by the formula —N═C(R5)— or the formula —NH—CH(R5)—, R1, R2, R3, and R4 represent a hydrogen atom, a halogen atom, a C1 to C6 alkyl group, or a hydroxy group, R5 represents a C1 to C6 alkyl group or a C6 to C10 aryl group, and R represents an amino group.